Literature DB >> 1322129

Binding of the cyclic AMP receptor protein of Escherichia coli and DNA bending at the P4 promoter of pBR322.

I Brierley1, J G Hoggett.   

Abstract

The binding of the Escherichia coli cyclic AMP receptor protein (CRP) to its specific site on the P4 promoter of pBR322 has been studied by gel electrophoresis. Binding to the P4 site was about 40-50-fold weaker than to the principal CRP site on the lactose promoter at both low (0.01 M) and high (0.1 M) ionic strengths. CRP-induced bending at the P4 site was investigated from the mobilities of CRP bound to circularly permuted P4 fragments. The estimated bending angle, based on comparison with Zinkel & Crothers [(1990) Biopolymers 29, 29-38] A-tract bending standards, was found to be approximately 96 degrees, similar to that found for binding to the lac site. These observations suggest that there is not a simple relationship between strength of CRP binding and the extent of induced bending for different CRP sites. The apparent centre of bending in P4 is displaced about 6-8 bp away from the conserved TGTGA sequence and the P4 transcription start site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322129      PMCID: PMC1132749          DOI: 10.1042/bj2850091

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Catabolite activator protein-induced DNA bending in transcription initiation.

Authors:  S S Zinkel; D M Crothers
Journal:  J Mol Biol       Date:  1991-05-20       Impact factor: 5.469

2.  Comparative gel electrophoresis measurement of the DNA bend angle induced by the catabolite activator protein.

Authors:  S S Zinkel; D M Crothers
Journal:  Biopolymers       Date:  1990-01       Impact factor: 2.505

3.  Determination of the extent of DNA bending by an adenine-thymine tract.

Authors:  H S Koo; J Drak; J A Rice; D M Crothers
Journal:  Biochemistry       Date:  1990-05-01       Impact factor: 3.162

4.  Mutations that alter the ability of the Escherichia coli cyclic AMP receptor protein to activate transcription.

Authors:  A Bell; K Gaston; R Williams; K Chapman; A Kolb; H Buc; S Minchin; J Williams; S Busby
Journal:  Nucleic Acids Res       Date:  1990-12-25       Impact factor: 16.971

5.  Bending of DNA by gene-regulatory proteins: construction and use of a DNA bending vector.

Authors:  J Kim; C Zwieb; C Wu; S Adhya
Journal:  Gene       Date:  1989-12-21       Impact factor: 3.688

6.  Consensus DNA site for the Escherichia coli catabolite gene activator protein (CAP): CAP exhibits a 450-fold higher affinity for the consensus DNA site than for the E. coli lac DNA site.

Authors:  R H Ebright; Y W Ebright; A Gunasekera
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

7.  Sequence-dependent contribution of distal binding domains to CAP protein-DNA binding affinity.

Authors:  D D Dalma-Weiszhausz; M R Gartenberg; D M Crothers
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

8.  Crystal structure of a CAP-DNA complex: the DNA is bent by 90 degrees.

Authors:  S C Schultz; G C Shields; T A Steitz
Journal:  Science       Date:  1991-08-30       Impact factor: 47.728

9.  The binding of cyclic AMP receptor protein to two lactose promoter sites is not cooperative in vitro.

Authors:  J M Hudson; M G Fried
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

10.  Synthetic curved DNA sequences can act as transcriptional activators in Escherichia coli.

Authors:  L Bracco; D Kotlarz; A Kolb; S Diekmann; H Buc
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  2 in total

1.  Chemical linkage at allosteric activation of E. coli cAMP receptor protein.

Authors:  Yusuf Tutar
Journal:  Protein J       Date:  2008-01       Impact factor: 2.371

2.  Kinetics of activation of the P4 promoter of pBR322 by the Escherichia coli cyclic AMP receptor protein.

Authors:  J G Hoggett; I Brierley
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.